These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 3498761)
21. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma. Chou T; Shu S J Immunol; 1987 Sep; 139(6):2103-9. PubMed ID: 2957448 [TBL] [Abstract][Full Text] [Related]
22. Hypersensitivity reactions in the small intestine. VII. Induction of the intestinal phase of murine graft-versus-host-reaction by Lyt 2- T cells activated by I-A alloantigens. Mowat AM; Borland A; Parrott DM Transplantation; 1986 Feb; 41(2):192-8. PubMed ID: 3484848 [TBL] [Abstract][Full Text] [Related]
23. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts. Sprent J; Schaefer M; Gao EK; Korngold R J Exp Med; 1988 Feb; 167(2):556-69. PubMed ID: 2964497 [TBL] [Abstract][Full Text] [Related]
24. Class II antigen-specific murine cytolytic T lymphocytes (CTL). II. Genuine class II specificity of Lyt-2+ CTL clones. Shinohara N; Hozumi N; Watanabe M; Bluestone JA; Johnson-Leva R; Sachs DH J Immunol; 1988 Jan; 140(1):30-6. PubMed ID: 3257229 [TBL] [Abstract][Full Text] [Related]
25. T cell antigen receptor expression by subsets of Ly-2-L3T4- (CD8-CD4-) thymocytes. Wilson A; Ewing T; Owens T; Scollay R; Shortman K J Immunol; 1988 Mar; 140(5):1470-6. PubMed ID: 2450128 [TBL] [Abstract][Full Text] [Related]
26. Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. Korngold R; Sprent J J Exp Med; 1987 Jun; 165(6):1552-64. PubMed ID: 3108446 [TBL] [Abstract][Full Text] [Related]
27. Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease. Friedman TM; Gilbert M; Briggs C; Korngold R J Immunol; 1998 Jul; 161(1):41-8. PubMed ID: 9647205 [TBL] [Abstract][Full Text] [Related]
28. Abrogation of the lethal graft-vs.-host reaction developed to non-H-2 antigens: involvement of T suppressor cells distinct from veto cells. Halle-Pannenko O; Pritchard LL; Bruley-Rosset M Eur J Immunol; 1987 Dec; 17(12):1751-5. PubMed ID: 2961574 [TBL] [Abstract][Full Text] [Related]
29. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution. Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113 [TBL] [Abstract][Full Text] [Related]
30. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras. Brochu S; Baron C; Hétu F; Roy DC; Perreault C J Immunol; 1995 Dec; 155(11):5104-14. PubMed ID: 7594519 [TBL] [Abstract][Full Text] [Related]
31. Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease. Schultz KR; Paquet J; Bader S; HayGlass KT Bone Marrow Transplant; 1995 Aug; 16(2):289-95. PubMed ID: 7581150 [TBL] [Abstract][Full Text] [Related]
32. Graft-versus-host reaction-induced immune modulation. I. Donor-recipient genetic disparity and the differential expression of Lyt-2, L3T4, and Ly-6 during acute reactions in the host thymus. Levy RB; Cotterell AH; Jones M; Malek TR J Immunol; 1988 Mar; 140(6):1717-25. PubMed ID: 3257983 [TBL] [Abstract][Full Text] [Related]
33. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. I. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis. Sugihara S; Izumi Y; Yoshioka T; Yagi H; Tsujimura T; Tarutani O; Kohno Y; Murakami S; Hamaoka T; Fujiwara H J Immunol; 1988 Jul; 141(1):105-13. PubMed ID: 2967864 [TBL] [Abstract][Full Text] [Related]
34. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants. Vallera DA; Soderling CC; Kersey JH J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513 [TBL] [Abstract][Full Text] [Related]
35. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity. Maier T; Holda JH; Claman HN J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774 [TBL] [Abstract][Full Text] [Related]
36. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody. Maeda T; Eto M; Lin T; Nishimura Y; Kong YY; Nomoto K; Nomoto K J Immunol; 1994 Nov; 153(9):4311-20. PubMed ID: 7930630 [TBL] [Abstract][Full Text] [Related]
37. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421 [TBL] [Abstract][Full Text] [Related]
38. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma. Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005 [TBL] [Abstract][Full Text] [Related]
39. The effect of T cell depletion from spleen cell allografts on graft-versus-host disease and long-term immune reconstitution in H-2 haplotype-identical murine combinations. Tokuda N; Mayumi H; Sakumoto M; Himeno K; Tomita Y; Nomoto K Immunobiology; 1989 Oct; 179(4-5):328-41. PubMed ID: 2515151 [TBL] [Abstract][Full Text] [Related]
40. The role of L3T4+ and Lyt-2+ T cells in the IgE response and immunity to Nippostrongylus brasiliensis. Katona IM; Urban JF; Finkelman FD J Immunol; 1988 May; 140(9):3206-11. PubMed ID: 2966208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]